17 enero 2010

J&J Y Pharma Mar han conseguido introducir el Velcade y el Yondelis respectivamente en UK , un ejemplo a seguir .

...
"Trabectedin is recommended as a treatment option for people with advanced soft tissue sarcoma if:


treatment with anthracyclines and ifosfamide has failed or
they are intolerant of or have contraindications for treatment with anthracyclines and ifosfamide and
the acquisition cost of trabectedin for treatment needed after the fifth cycle is met by the manufacturer."
...